When to use GPIIb/IIIa receptor antagonists: pre-, peri- or post MI intervention? + case discussion
Presentation by prof. Kurt Huber, MD, Wilhelminen hospital, Vienna, Austria held at PACE symposium '20 years clinical use of GP IIb/IIIa receptor antagonists: What have we learned and where to go? on September 1, 2014 at ESC in Barcelona.
Download When to use GPIIb IIIa receptor antagonists. dr Huber.pdf
Download When to use GPIIb IIIa receptor antagonists. dr Huber.pdf
To view slides, click on images
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: